Ratliff v. Novo Nordisk A/S et al
Melissa Ratliff |
NOVO NORDISK A/S, NOVO NORDISK NORTH AMERICA OPERATIONS A/S, NOVO NORDISK INC., NOVO NORDISK RESEARCH CENTER SEATTLE INC., NOVO NORDISK US COMMERCIAL HOLDINGS INC., NOVO NORDISK US HOLDINGS INC. and NOVO NORDISK PHARMACEUTICAL INDUSTRIES L.P. |
2:2024cv04269 |
August 16, 2024 |
U.S. District Court for the Eastern District of Pennsylvania |
KAREN S MARSTON |
P.I.: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 Diversity-Product Liability |
Plaintiff |
Docket Report
This docket was last retrieved on August 16, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 9 Case transferred in from District of Tennessee Middle; Case Number 3:24-cv-00822. Original file certified copy of transfer order and docket sheet received. |
This case has been transferred to the United States District Court for the Eastern District of Pennsylvania. (kc) [Transferred from Tennessee Middle on 8/16/2024.] |
***Civil Case Terminated per Text Order 8 . (kc) [Transferred from Tennessee Middle on 8/16/2024.] |
***DISREGARD. ENTERED IN ERROR.*** This case has been transferred to the United States District Court for the Eastern District of Pennsylvania. (kc) Modified on 8/16/2024 (kc). [Transferred from Tennessee Middle on 8/16/2024.] |
MDL-3094 (Judge MARSTON) Member Case. Middle District of Tennessee, 3:24-cv-822. Case number in EDPA: 24-cv-4269. (sbt) |
![]() |
Filing 7 CERTIFIED CONDITIONAL TRANSFER (CTO-20) ORDER IN RE GLUCAGONLIKE PEPTIDE1 RECEPTOR AGONISTS (GLP1 RAS) PRODUCTS LIABILITY LITIGATION, MDL 3094 received from Eastern District of Pennsylvania. (Case ready for closing/transfer)(hb) [Transferred from Tennessee Middle on 8/16/2024.] |
![]() |
Filing 5 NOTICE of Initial Case Management Conference by Telephone is set for 9/4/2024 at 09:30 AM before Magistrate Judge Alistair Newbern. (kc) [Transferred from Tennessee Middle on 8/16/2024.] |
Filing 4 NOTICE/INFORMATION regarding Consent of the Parties to the Magistrate Judge. (kc) [Transferred from Tennessee Middle on 8/16/2024.] |
Filing 3 NOTICE of Business Entity Disclosure Statement filing requirement. (kc) [Transferred from Tennessee Middle on 8/16/2024.] |
Filing 2 NOTICE OF ADMINISTRATIVE ORDER NO. 217 to parties re obligation of counsel to keep Court apprised of current contact information. (kc) [Transferred from Tennessee Middle on 8/16/2024.] |
Filing 1 COMPLAINT against Novo Nordisk A/S, Novo Nordisk Inc., Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries LP, Novo Nordisk Research Center Seattle, Inc., Novo Nordisk US Commercial Holdings Inc., Novo Nordisk US Holdings Inc. (Filing fee $405, Receipt number ATNMDC-4114946), filed by Melissa Ratliff. (Attachments: #1 Attachment - Civil Cover Sheet)(kc) [Transferred from Tennessee Middle on 8/16/2024.] |
TN State Bar status verified as active for Carolyn Delyliah Dale admitted to this court. (kc) [Transferred from Tennessee Middle on 8/16/2024.] |
NY State Bar status verified as active for Paul J. Pennock, Jonathan M. Sedgh not admitted to this court - Local counsel secured. (kc) [Transferred from Tennessee Middle on 8/16/2024.] |
NOTICE TO COUNSEL Paul J. Pennock, Jonathan M. Sedgh: WITHIN 21 DAYS, counsel shall file a Motion to Appear Pro Hac Vice, a Certificate of Good Standing signed by the Clerk of a United States District Court or a U. S. appellate court where admitted, and pay a fee of $150.00 (LR 83.01(b)). PHV due by 7/30/2024. (kc) [Transferred from Tennessee Middle on 8/16/2024.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Pennsylvania Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.